Plastic Surgery Doctors in Southlake, TX Accepting Medicare

6 Plastic Surgery doctors found. Showing 1 - 6

Dr. Scott Edward Kasden, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2813 W Southlake Blvd Suite 130, Suite 130, Southlake, TX 76092 Phone: 817-416-9980    Fax: 817-337-7379

Sacha Imran Obaid, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1545 E Southlake Blvd, Suite 250, Southlake, TX 76092 Phone: 214-663-4339

Matthew Novak, M.D. Plastic Surgery Medicare: Medicare Enrolled Practice Location: 900 E Southlake Blvd Ste 100, Southlake, TX 76092 Phone: 817-442-8900    Fax: 817-488-2490

Tarik David Madni, M.D. Plastic Surgery Medicare: Medicare Enrolled Practice Location: 245 W State Highway 114 Ste 100, Southlake, TX 76092 Phone: 817-912-1200    Fax: 817-997-8791

Michael A Bogdan, MD, FACS Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 410 N Carroll Ave, Suite 170, Southlake, TX 76092 Phone: 817-442-1236    Fax: 817-442-1247

Dr. Ameen Habash, M.D. Plastic Surgery Medicare: May Accept Medicare Assignments Practice Location: 1100 E Southlake Blvd Ste 250, Southlake, TX 76092 Phone: 817-484-0222    Fax: 817-484-0223

News Archive

Pierre Fabre Dermatologie receives FDA marketing authorization for pediatric drug Hemangeol

Pierre Fabre Dermatologie has obtained marketing authorization from the FDA for the pediatric drug Hemangeol (propranolol hydrochloride), which is the first and only approved treatment for "proliferating infantile hemangioma requiring systemic therapy".

Catholic Health Partners implements Phytel's Proactive Patient Outreach solution

Phytel today announced that Catholic Health Partners (CHP) has successfully implemented Phytel's Proactive Patient Outreach solution in its Knoxville, TN; Youngstown, OH; and Paducah, KY facilities. In 2011, Phytel technology will be implemented in these CHP regions in Ohio: Toledo, Cincinnati, Lorain and Lima.

New York Academy of Sciences and Zeltia to host marine drug discovery forum on May 20, 2011

Substances produced by living organisms found in nature-so-called "natural products"-have played a critical role in the development of drugs for life-threatening conditions. The anticancer agent Taxol was sourced from a plant, penicillin from a fungus, and a number of recent breakthroughs have resulted in the development and approval of anticancer drugs derived from marine sources such as coral and sponges.

BioElectronics announces distribution agreement with Ream Surgical

BioElectronics Corporation has announced that Ream Surgical Ltd. has signed an agreement and issued their initial purchase order for the distribution of ActiPatch in the United Kingdom.

Fast-tracked H1N1 vaccines will not compromise safety, WHO says

Efforts to fast-track the approval of H1N1 (swine) flu vaccines will not compromise the safety or quality controls of vaccine production, the WHO said in a written statement Thursday, the Mail & Guardian reports.

Read more Medical News

› Verified 8 days ago